Announcements Trials
Browse Landscape

Phase

Phase NA 41Phase 2 3

Status

Completed 3Active not recruiting 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 1Genitourinary 1CNS 1Breast 1

Conditions

Sleep Initiation and Maintenance Disorders 1Sedentary Behavior 1Prostatic Neoplasms 1Oligodendroglioma 1Meningioma 1Lymphoma 1Glioma 1Glioblastoma 1Breast Neoplasms 1Brain Neoplasms 1Astrocytoma 1

Interventions

Cyclophosphamide 739Cisplatin 687Gemcitabine 641Bevacizumab 615Carboplatin 604Paclitaxel 600Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 360Capecitabine 342Filgrastim 333Etoposide 328Dexamethasone 312Irinotecan 309pembrolizumab 279Leucovorin 274Cetuximab 267Cytarabine 242Erlotinib Hydrochloride 231Prednisone 227Nivolumab 227Trastuzumab 225Bortezomib 221Vincristine 220Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Completed × Cognitive Behavioral Therapy × Clear all
NCT03421782 2026-02-17

Fatigue Interventions in Cancer (Exercise Intervention)

University of Utah

Phase 2 Completed
126 enrolled
Genitourinary

Prostatic Neoplasms, Sedentary Behavior

NCT06439420 2025-10-01

CBT-I in PBT

Virginia Commonwealth University

Phase 2 Completed
70 enrolled
CNSLymphoid

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Sleep Initiation and Maintenance Disorders, Lymphoma, Meningioma, Oligodendroglioma

NCT01797354 2015-09-04

Impact of a Group Intervention on Breast Cancer Patient's Adjustment and Emotion Regulation at the End of Treatment

Université Libre de Bruxelles

Phase 2 Completed
260 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡